Topics

Eli Lilly's Taltz improves rates of skin clearance versus Johnson & Johnson's Tremfya in head-to-head psoriasis study https://www.firstwordpharma.com/node/1671337  $LLY $JNJ

12:41 EDT 3 Oct 2019 | FirstWord Pharma

Eli Lilly's Taltz improves rates of skin clearance versus Johnson & Johnson's Tremfya in head-to-head psoriasis study https://www.firstwordpharma.com/node/1671337 

Original Article: Eli Lilly's Taltz improves rates of skin clearance versus Johnson & Johnson's Tremfya in head-to-head psoriasis study https://www.firstwordpharma.com/node/1671337  $LLY $JNJ

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly's Taltz improves rates of skin clearance versus Johnson & Johnson's Tremfya in head-to-head psoriasis study https://www.firstwordpharma.com/node/1671337  $LLY $JNJ"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...